The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Paclitaxel-eluting Stent Market Research Report 2025
Synopsis
Paclitaxel-eluting stent is used to prevent cell proliferation and avoid fibrosis that could block the stented artery with the clots in a process called restenosis. The stents are scaffolds that can be placed inside diseased or narrowed coronary arteries to release a drug (at a slow speed) to inhibit cell proliferation.
The global Paclitaxel-eluting Stent market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Paclitaxel-eluting Stent is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Paclitaxel-eluting Stent is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Paclitaxel-eluting Stent include Blue Medical, Boston Scientific, DISA Vascular, Essen, Medtronic Vascular, MicroPort Medical, Terumo Medical, Orbusneich and Cook Medical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Paclitaxel-eluting Stent, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Paclitaxel-eluting Stent.
Report Scope
The Paclitaxel-eluting Stent market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Paclitaxel-eluting Stent market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Paclitaxel-eluting Stent manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Blue Medical
Boston Scientific
DISA Vascular
Essen
Medtronic Vascular
MicroPort Medical
Terumo Medical
Orbusneich
Cook Medical
Segment by Type
Metal Stent
Polymer Stent
Others
Segment by Application
Coronary Heart Disease
Clinical
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Paclitaxel-eluting Stent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Paclitaxel-eluting Stent in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Paclitaxel-eluting stent is used to prevent cell proliferation and avoid fibrosis that could block the stented artery with the clots in a process called restenosis. The stents are scaffolds that can be placed inside diseased or narrowed coronary arteries to release a drug (at a slow speed) to inhibit cell proliferation.
The global Paclitaxel-eluting Stent market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Paclitaxel-eluting Stent is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Paclitaxel-eluting Stent is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Paclitaxel-eluting Stent include Blue Medical, Boston Scientific, DISA Vascular, Essen, Medtronic Vascular, MicroPort Medical, Terumo Medical, Orbusneich and Cook Medical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Paclitaxel-eluting Stent, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Paclitaxel-eluting Stent.
Report Scope
The Paclitaxel-eluting Stent market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Paclitaxel-eluting Stent market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Paclitaxel-eluting Stent manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Blue Medical
Boston Scientific
DISA Vascular
Essen
Medtronic Vascular
MicroPort Medical
Terumo Medical
Orbusneich
Cook Medical
Segment by Type
Metal Stent
Polymer Stent
Others
Segment by Application
Coronary Heart Disease
Clinical
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Paclitaxel-eluting Stent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Paclitaxel-eluting Stent in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Paclitaxel-eluting Stent Market Overview
1.1 Product Overview and Scope of Paclitaxel-eluting Stent
1.2 Paclitaxel-eluting Stent Segment by Type
1.2.1 Global Paclitaxel-eluting Stent Market Value Comparison by Type (2024-2030)
1.2.2 Metal Stent
1.2.3 Polymer Stent
1.2.4 Others
1.3 Paclitaxel-eluting Stent Segment by Application
1.3.1 Global Paclitaxel-eluting Stent Market Value by Application: (2024-2030)
1.3.2 Coronary Heart Disease
1.3.3 Clinical
1.3.4 Others
1.4 Global Paclitaxel-eluting Stent Market Size Estimates and Forecasts
1.4.1 Global Paclitaxel-eluting Stent Revenue 2019-2030
1.4.2 Global Paclitaxel-eluting Stent Sales 2019-2030
1.4.3 Global Paclitaxel-eluting Stent Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Paclitaxel-eluting Stent Market Competition by Manufacturers
2.1 Global Paclitaxel-eluting Stent Sales Market Share by Manufacturers (2019-2024)
2.2 Global Paclitaxel-eluting Stent Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Paclitaxel-eluting Stent Average Price by Manufacturers (2019-2024)
2.4 Global Paclitaxel-eluting Stent Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Paclitaxel-eluting Stent, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Paclitaxel-eluting Stent, Product Type & Application
2.7 Paclitaxel-eluting Stent Market Competitive Situation and Trends
2.7.1 Paclitaxel-eluting Stent Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Paclitaxel-eluting Stent Players Market Share by Revenue
2.7.3 Global Paclitaxel-eluting Stent Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Paclitaxel-eluting Stent Retrospective Market Scenario by Region
3.1 Global Paclitaxel-eluting Stent Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Paclitaxel-eluting Stent Global Paclitaxel-eluting Stent Sales by Region: 2019-2030
3.2.1 Global Paclitaxel-eluting Stent Sales by Region: 2019-2024
3.2.2 Global Paclitaxel-eluting Stent Sales by Region: 2025-2030
3.3 Global Paclitaxel-eluting Stent Global Paclitaxel-eluting Stent Revenue by Region: 2019-2030
3.3.1 Global Paclitaxel-eluting Stent Revenue by Region: 2019-2024
3.3.2 Global Paclitaxel-eluting Stent Revenue by Region: 2025-2030
3.4 North America Paclitaxel-eluting Stent Market Facts & Figures by Country
3.4.1 North America Paclitaxel-eluting Stent Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Paclitaxel-eluting Stent Sales by Country (2019-2030)
3.4.3 North America Paclitaxel-eluting Stent Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Paclitaxel-eluting Stent Market Facts & Figures by Country
3.5.1 Europe Paclitaxel-eluting Stent Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Paclitaxel-eluting Stent Sales by Country (2019-2030)
3.5.3 Europe Paclitaxel-eluting Stent Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Paclitaxel-eluting Stent Market Facts & Figures by Country
3.6.1 Asia Pacific Paclitaxel-eluting Stent Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Paclitaxel-eluting Stent Sales by Country (2019-2030)
3.6.3 Asia Pacific Paclitaxel-eluting Stent Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Paclitaxel-eluting Stent Market Facts & Figures by Country
3.7.1 Latin America Paclitaxel-eluting Stent Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Paclitaxel-eluting Stent Sales by Country (2019-2030)
3.7.3 Latin America Paclitaxel-eluting Stent Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Paclitaxel-eluting Stent Market Facts & Figures by Country
3.8.1 Middle East and Africa Paclitaxel-eluting Stent Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Paclitaxel-eluting Stent Sales by Country (2019-2030)
3.8.3 Middle East and Africa Paclitaxel-eluting Stent Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Paclitaxel-eluting Stent Sales by Type (2019-2030)
4.1.1 Global Paclitaxel-eluting Stent Sales by Type (2019-2024)
4.1.2 Global Paclitaxel-eluting Stent Sales by Type (2025-2030)
4.1.3 Global Paclitaxel-eluting Stent Sales Market Share by Type (2019-2030)
4.2 Global Paclitaxel-eluting Stent Revenue by Type (2019-2030)
4.2.1 Global Paclitaxel-eluting Stent Revenue by Type (2019-2024)
4.2.2 Global Paclitaxel-eluting Stent Revenue by Type (2025-2030)
4.2.3 Global Paclitaxel-eluting Stent Revenue Market Share by Type (2019-2030)
4.3 Global Paclitaxel-eluting Stent Price by Type (2019-2030)
5 Segment by Application
5.1 Global Paclitaxel-eluting Stent Sales by Application (2019-2030)
5.1.1 Global Paclitaxel-eluting Stent Sales by Application (2019-2024)
5.1.2 Global Paclitaxel-eluting Stent Sales by Application (2025-2030)
5.1.3 Global Paclitaxel-eluting Stent Sales Market Share by Application (2019-2030)
5.2 Global Paclitaxel-eluting Stent Revenue by Application (2019-2030)
5.2.1 Global Paclitaxel-eluting Stent Revenue by Application (2019-2024)
5.2.2 Global Paclitaxel-eluting Stent Revenue by Application (2025-2030)
5.2.3 Global Paclitaxel-eluting Stent Revenue Market Share by Application (2019-2030)
5.3 Global Paclitaxel-eluting Stent Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Blue Medical
6.1.1 Blue Medical Corporation Information
6.1.2 Blue Medical Description and Business Overview
6.1.3 Blue Medical Paclitaxel-eluting Stent Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Blue Medical Paclitaxel-eluting Stent Product Portfolio
6.1.5 Blue Medical Recent Developments/Updates
6.2 Boston Scientific
6.2.1 Boston Scientific Corporation Information
6.2.2 Boston Scientific Description and Business Overview
6.2.3 Boston Scientific Paclitaxel-eluting Stent Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Boston Scientific Paclitaxel-eluting Stent Product Portfolio
6.2.5 Boston Scientific Recent Developments/Updates
6.3 DISA Vascular
6.3.1 DISA Vascular Corporation Information
6.3.2 DISA Vascular Description and Business Overview
6.3.3 DISA Vascular Paclitaxel-eluting Stent Sales, Revenue and Gross Margin (2019-2024)
6.3.4 DISA Vascular Paclitaxel-eluting Stent Product Portfolio
6.3.5 DISA Vascular Recent Developments/Updates
6.4 Essen
6.4.1 Essen Corporation Information
6.4.2 Essen Description and Business Overview
6.4.3 Essen Paclitaxel-eluting Stent Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Essen Paclitaxel-eluting Stent Product Portfolio
6.4.5 Essen Recent Developments/Updates
6.5 Medtronic Vascular
6.5.1 Medtronic Vascular Corporation Information
6.5.2 Medtronic Vascular Description and Business Overview
6.5.3 Medtronic Vascular Paclitaxel-eluting Stent Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Medtronic Vascular Paclitaxel-eluting Stent Product Portfolio
6.5.5 Medtronic Vascular Recent Developments/Updates
6.6 MicroPort Medical
6.6.1 MicroPort Medical Corporation Information
6.6.2 MicroPort Medical Description and Business Overview
6.6.3 MicroPort Medical Paclitaxel-eluting Stent Sales, Revenue and Gross Margin (2019-2024)
6.6.4 MicroPort Medical Paclitaxel-eluting Stent Product Portfolio
6.6.5 MicroPort Medical Recent Developments/Updates
6.7 Terumo Medical
6.6.1 Terumo Medical Corporation Information
6.6.2 Terumo Medical Description and Business Overview
6.6.3 Terumo Medical Paclitaxel-eluting Stent Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Terumo Medical Paclitaxel-eluting Stent Product Portfolio
6.7.5 Terumo Medical Recent Developments/Updates
6.8 Orbusneich
6.8.1 Orbusneich Corporation Information
6.8.2 Orbusneich Description and Business Overview
6.8.3 Orbusneich Paclitaxel-eluting Stent Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Orbusneich Paclitaxel-eluting Stent Product Portfolio
6.8.5 Orbusneich Recent Developments/Updates
6.9 Cook Medical
6.9.1 Cook Medical Corporation Information
6.9.2 Cook Medical Description and Business Overview
6.9.3 Cook Medical Paclitaxel-eluting Stent Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Cook Medical Paclitaxel-eluting Stent Product Portfolio
6.9.5 Cook Medical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Paclitaxel-eluting Stent Industry Chain Analysis
7.2 Paclitaxel-eluting Stent Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Paclitaxel-eluting Stent Production Mode & Process
7.4 Paclitaxel-eluting Stent Sales and Marketing
7.4.1 Paclitaxel-eluting Stent Sales Channels
7.4.2 Paclitaxel-eluting Stent Distributors
7.5 Paclitaxel-eluting Stent Customers
8 Paclitaxel-eluting Stent Market Dynamics
8.1 Paclitaxel-eluting Stent Industry Trends
8.2 Paclitaxel-eluting Stent Market Drivers
8.3 Paclitaxel-eluting Stent Market Challenges
8.4 Paclitaxel-eluting Stent Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
